TITLE

LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice

AUTHOR(S)
Patel, Rucha; Patel, Monika; Tsai, Ricky; Lin, Vicky; Bookout, Angie L.; Yuan Zhang; Magomedova, Lilia; Tingting Li; Chan, Jessica F.; Budd, Conrad; Mangelsdorf, David J.; Cummins, Carolyn L.; Zhang, Yuan; Li, Tingting
PUB. DATE
January 2011
SOURCE
Journal of Clinical Investigation;Jan2011, Vol. 121 Issue 1, p431
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Although widely prescribed for their potent antiinflammatory actions, glucocorticoid drugs (e.g., dexamethasone) cause undesirable side effects that are features of the metabolic syndrome, including hyperglycemia, fatty liver, insulin resistance, and type II diabetes. Liver x receptors (LXRs) are nuclear receptors that respond to cholesterol metabolites and regulate the expression of a subset of glucocorticoid target genes. Here, we show LXRβ is required to mediate many of the negative side effects of glucocorticoids. Mice lacking LXRβ (but not LXRα) were resistant to dexamethasone-induced hyperglycemia, hyperinsulinemia, and hepatic steatosis, but remained sensitive to dexamethasone-dependent repression of the immune system. In vivo, LXRα/β knockout mice demonstrated reduced dexamethasone-induced expression of the key hepatic gluconeogenic gene, phosphoenolpyruvate carboxykinase (PEPCK). In perfused liver and primary mouse hepatocytes, LXRβ was required for glucocorticoid-induced recruitment of the glucocorticoid receptor to the PEPCK promoter. These findings suggest a new avenue for the design of safer glucocorticoid drugs through a mechanism of selective glucocorticoid receptor transactivation.
ACCESSION #
58077580

 

Related Articles

  • Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. Seongah Han; Chien-Ping Liang; Westerterp, Marit; Senokuchi, Takafumi; Welch, Carrie L.; Qizhi Wang; Matsumoto, Michihiro; Accili, Domenico; Tall, Alan R.; Han, Seongah; Liang, Chien-Ping; Wang, Qizhi // Journal of Clinical Investigation;Apr2009, Vol. 119 Issue 4, p1 

    Type 2 diabetes is associated with accelerated atherogenesis, which may result from a combination of factors, including dyslipidemia characterized by increased VLDL secretion, and insulin resistance. To assess the hypothesis that both hepatic and peripheral insulin resistance contribute to...

  • Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. Samuel, Varman T.; Zhen-Xiang Liu; Wang, Amy; Beddow, Sara A.; Geisler, John G.; Kahn, Mario; Xian-man Zhang; Monia, Brett P.; Bhanot, Sanjay; Shulman, Gerald I.; Liu, Zhen-Xiang; Zhang, Xian-man // Journal of Clinical Investigation;Mar2007, Vol. 117 Issue 3, p739 

    Nonalcoholic fatty liver disease is strongly associated with hepatic insulin resistance and type 2 diabetes mellitus, but the molecular signals linking hepatic fat accumulation to hepatic insulin resistance are unknown. Three days of high-fat feeding in rats results specifically in hepatic...

  • Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. Buettner, Christoph; Patel, Rima; Muse, Evan D.; Bhanot, Sanjay; Monia, Brett P.; Mckay, Rob; Obici, Silvana; Rossetti, Luciano // Journal of Clinical Investigation;May2005, Vol. 115 Issue 5, p1306 

    Insulin exerts its potent effects on hepatic glucose fluxes via direct and indirect mechanisms. Whereas a liver-specific insulin receptor (IR) knockout (LIRKO) mouse exhibits glucose intolerance as well as insulin resistance, it is unclear whether a more acute decrease in the expression of...

  • Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes. Tiano, Joseph P.; Delghingaro-Augusto, Viviane; Le May, Cedric; Suhuan Liu; Kaw, Meenakshi K.; Khuder, Saja S.; Latour, Martin G.; Bhatt, Surabhi A.; Korach, Kenneth S.; Najjar, Sonia M.; Prentki, Marc; Mauvais-Jarvis, Franck; Liu, Suhuan // Journal of Clinical Investigation;Aug2011, Vol. 121 Issue 8, p3331 

    The failure of pancreatic β cells to adapt to an increasing demand for insulin is the major mechanism by which patients progress from insulin resistance to type 2 diabetes (T2D) and is thought to be related to dysfunctional lipid homeostasis within those cells. In multiple animal models of...

  • Chemokine antagonism in chronic hepatitis C virus infection. Charles, Edgar D.; Dustin, Lynn B. // Journal of Clinical Investigation;Jan2011, Vol. 121 Issue 1, p25 

    Immune responses to hepatitis C virus (HCV) fail to clear the virus in most individuals. Why patients who are less likely to clear HCV infection have high plasma levels of CXCL10 (also known as IP-10), a chemokine that directs T cells to sites of infection, has long been unclear. In this issue...

  • Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes. Fujimoto, Kei; Ford, Eric L.; Hung Tran; Wice, Burton M.; Crosby, Seth D.; Dorn II, Gerald W.; Polonsky, Kenneth S.; Tran, Hung; Dorn, Gerald W 2nd // Journal of Clinical Investigation;Nov2010, Vol. 120 Issue 11, p4031 

    Mutations in pancreatic duodenal homeobox (PDX1) are linked to human type 2 diabetes and maturity-onset diabetes of the young type 4. Consistent with this, Pdx1-haploinsufficient mice develop diabetes. Both apoptosis and necrosis of β cells are mechanistically implicated in diabetes in these...

  • Farnesoid X receptor is essential for normal glucose homeostasis. Ma, Ke; Saha, Pradip K.; Chan, Lawrence; Moore, David D. // Journal of Clinical Investigation;Apr2006, Vol. 116 Issue 4, p1102 

    The bile acid receptor farnesoid X receptor (FXR; NR1H4) is a central regulator of bile acid and lipid metabolism. We show here that FXR plays a key regulatory role in glucose homeostasis. FXR-null mice developed severe fatty liver and elevated circulating FFAs, which was associated with...

  • Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. Wanzhu Jin; Goldfine, Allison B.; Boes, Tanner; Henry, Robert R.; Ciaraldi, Theodore P.; Eun-Young Kim; Emecan, Merve; Fitzpatrick, Connor; Sen, Anish; Shah, Ankit; Mun, Edward; Vokes, Martha; Schroeder, Joshua; Tatro, Elizabeth; Jimenez-Chillaron, Jose; Patti, Mary-Elizabeth; Jin, Wanzhu; Kim, Eun-Young; Vokes, Vokes // Journal of Clinical Investigation;Mar2011, Vol. 121 Issue 3, p918 

    Insulin resistance in skeletal muscle is a key phenotype associated with type 2 diabetes (T2D) for which the molecular mediators remain unclear. We therefore conducted an expression analysis of human muscle biopsies from patients with T2D; normoglycemic but insulin-resistant subjects with a...

  • Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. Petersen, Max C.; Madiraju, Anila K.; Gassaway, Brandon M.; Marcel, Michael; Nasiri, Ali R.; Butrico, Gina; Marcucci, Melissa J.; Dongyan Zhang; Abulizi, Abudukadier; Xian-Man Zhang; Philbrick, William; Hubbard, Stevan R.; Jurczak, Michael J.; Samuel, Varman T.; Rinehart, Jesse; Shulman, Gerald I.; Zhang, Dongyan; Zhang, Xian-Man // Journal of Clinical Investigation;Nov2016, Vol. 126 Issue 11, p4361 

    Nonalcoholic fatty liver disease (NAFLD) is a risk factor for type 2 diabetes (T2D), but whether NAFLD plays a causal role in the pathogenesis of T2D is uncertain. One proposed mechanism linking NAFLD to hepatic insulin resistance involves diacylglycerol-mediated (DAG-mediated) activation of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics